 |
Prescription and Over-the-Counter Drug Product List
28th Edition
Cumulative Supplement Number 4: April 2008
NOTE: The format for the Monthly Additions/Deletions Drug
Product List changed as of the July Cumulative Supplement (CS) of the 21st
Edition to mirror the CS. Refer to the CS Preface section 1.6
Cumulative Supplement Legend. 
ACARBOSE
TABLET; ORAL
>A> ACARBOSE
>A> AB COBALT LABS INC 25MG N77532 001 May 07, 2008 Apr NEWA
>A> AB 50MG N77532 002 May 07, 2008 Apr NEWA
>A> AB 100MG N77532 003 May 07, 2008 Apr NEWA
>A> AB ROXANE 25MG N78470 001 May 07, 2008 Apr NEWA
>A> AB 50MG N78470 002 May 07, 2008 Apr NEWA
>A> AB 100MG N78470 003 May 07, 2008 Apr NEWA
PRECOSE
>D> BAYER PHARMS 25MG N20482 004 May 29, 1997 Apr CFTG
>A> AB 25MG N20482 004 May 29, 1997 Apr CFTG
>D> 50MG N20482 001 Sep 06, 1995 Apr CFTG
>A> AB 50MG N20482 001 Sep 06, 1995 Apr CFTG
>D> 100MG N20482 002 Sep 06, 1995 Apr CFTG
>A> AB 100MG N20482 002 Sep 06, 1995 Apr CFTG
ACETAMINOPHEN; HYDROCODONE BITARTRATE
SOLUTION; ORAL
HYDROCODONE BITARTRATE AND ACETAMINOPHEN
>A> + PHARM ASSOC 325MG/15ML;10MG/15ML N40834 001 Apr 18, 2008 Apr NEWA
ALBUTEROL SULFATE; IPRATROPIUM BROMIDE
SOLUTION; INHALATION
ALBUTEROL SULFATE AND IPRATROPIUM BROMIDE
>D> AN BREATH LTD EQ 0.083% BASE;0.017% N77063 001 Dec 31, 2007 Apr CAHN
>A> AN COBALT LABS INC EQ 0.083% BASE;0.017% N77063 001 Dec 31, 2007 Apr CAHN
AMIODARONE HYDROCHLORIDE
INJECTABLE; INJECTION
AMIODARONE HYDROCHLORIDE
>D> AP + BEN VENUE 50MG/ML N76088 001 Oct 15, 2002 Apr DISC
>A> @ 50MG/ML N76088 001 Oct 15, 2002 Apr DISC
ARIPIPRAZOLE
TABLET, ORALLY DISINTEGRATING; ORAL
ABILIFY
>D> OTSUKA 20MG N21729 004 Jun 07, 2006 Apr DISC
>A> @ 20MG N21729 004 Jun 07, 2006 Apr DISC
>D> 30MG N21729 005 Jun 07, 2006 Apr DISC
>A> @ 30MG N21729 005 Jun 07, 2006 Apr DISC
ATROPINE SULFATE; DIPHENOXYLATE HYDROCHLORIDE
TABLET; ORAL
DIPHENOXYLATE HYDROCHLORIDE W/ ATROPINE SULFATE
>D> @ LEINER 0.025MG;2.5MG N85766 001 Apr CAHN
>A> @ PVT FORM 0.025MG;2.5MG N85766 001 Apr CAHN
BENZTHIAZIDE
TABLET; ORAL
BENZTHIAZIDE
>D> @ LEINER 50MG N83206 001 Apr CAHN
>A> @ PVT FORM 50MG N83206 001 Apr CAHN
BUMETANIDE
INJECTABLE; INJECTION
BUMETANIDE
>A> AP BAXTER HLTHCARE 0.25MG/ML N79196 001 Apr 30, 2008 Apr NEWA
BUPIVACAINE HYDROCHLORIDE; EPINEPHRINE
INJECTABLE; INJECTION
BUPIVACAINE HYDROCHLORIDE AND EPINEPHRINE
>D> HOSPIRA 0.5%;0.005MG/ML N71169 001 Jun 16, 1988 Apr DISC
>A> @ 0.5%;0.005MG/ML N71169 001 Jun 16, 1988 Apr DISC
>D> + 0.75%;0.005MG/ML N71171 001 Jun 16, 1988 Apr DISC
>A> @ 0.75%;0.005MG/ML N71171 001 Jun 16, 1988 Apr DISC
>A> BUPROPION HYDROBROMIDE
>A> TABLET, EXTENDED RELEASE; ORAL
>A> APLENZIN
>A> + BIOVAIL LABS INTL 174MG N22108 001 Apr 23, 2008 Apr NEWA
>A> 348MG N22108 002 Apr 23, 2008 Apr NEWA
>A> 522MG N22108 003 Apr 23, 2008 Apr NEWA
CABERGOLINE
TABLET; ORAL
CABERGOLINE
>A> AB COBALT LABS INC 0.5MG N78035 001 Apr 21, 2008 Apr NEWA
>D> AB PAR PHARM 0.5MG N76310 001 Dec 29, 2005 Apr CRLD
>A> AB + 0.5MG N76310 001 Dec 29, 2005 Apr CRLD
>D> DOSTINEX
>D> AB + PHARMACIA AND 0.5MG N20664 001 Dec 23, 1996 Apr DISC
>A> @ 0.5MG N20664 001 Dec 23, 1996 Apr DISC
CALCIPOTRIENE
SOLUTION; TOPICAL
>A> CALCIPOTRIENE
>A> AT NYCOMED US 0.005% N78305 001 May 06, 2008 Apr NEWA
DOVONEX
>D> + LEO PHARM 0.005% N20611 001 Mar 03, 1997 Apr CFTG
>A> AT + 0.005% N20611 001 Mar 03, 1997 Apr CFTG
CALCIUM ACETATE
TABLET; ORAL
CALCIUM ACETATE
>D> + ROXANE EQ 169MG CALCIUM N77693 001 Jan 30, 2008 Apr DISC
>A> @ EQ 169MG CALCIUM N77693 001 Jan 30, 2008 Apr DISC
CARBOPLATIN
INJECTABLE; IV (INFUSION)
CARBOPLATIN
>A> AP EBEWE PHARMA EQ 50MG/5ML(10MG/ML) N78280 001 May 08, 2008 Apr NEWA
>A> AP EQ 150MG/15ML(10MG/ML) N78280 002 May 08, 2008 Apr NEWA
>A> AP EQ 450MG/45ML(10MG/ML) N78280 003 May 08, 2008 Apr NEWA
CEFIXIME
TABLET; ORAL
SUPRAX
>D> @ LUPIN 400MG N65130 001 Feb 12, 2004 Apr CMFD
>A> + 400MG N65130 001 Feb 12, 2004 Apr CMFD
CHLORPHENIRAMINE MALEATE
TABLET; ORAL
CHLORPHENIRAMINE MALEATE
>D> @ LEINER 4MG N80786 001 Apr CAHN
>A> @ PVT FORM 4MG N80786 001 Apr CAHN
CHLORPROMAZINE HYDROCHLORIDE
TABLET; ORAL
CHLORPROMAZINE HYDROCHLORIDE
>D> @ LEINER 25MG N80340 001 Apr CAHN
>D> @ 50MG N80340 002 Apr CAHN
>D> @ 200MG N80340 003 Apr CAHN
>A> @ PVT FORM 25MG N80340 001 Apr CAHN
>A> @ 50MG N80340 002 Apr CAHN
>A> @ 200MG N80340 003 Apr CAHN
CIPROFLOXACIN
INJECTABLE; INJECTION
CIPROFLOXACIN
>A> AP CLARIS 200MG/20ML (10MG/ML) N78062 001 Apr 29, 2008 Apr NEWA
>A> AP 400MG/40ML (10MG/ML) N78062 002 Apr 29, 2008 Apr NEWA
CIPROFLOXACIN IN DEXTROSE 5% IN PLASTIC CONTAINER
>A> AP HIKMA 200MG/100ML N76757 001 Apr 21, 2008 Apr NEWA
>D> CITRIC ACID; MAGNESIUM OXIDE; SODIUM CARBONATE
>D> SOLUTION; IRRIGATION
>D> UROLOGIC G IN PLASTIC CONTAINER
>D> + HOSPIRA 3.24GM/100ML;380MG/100ML;430MG/ N18904 001 May 27, 1983 Apr DISC
>A> @ 3.24GM/100ML;380MG/100ML;430MG/ N18904 001 May 27, 1983 Apr DISC
CLINDAMYCIN PHOSPHATE
SOLUTION; TOPICAL
CLINDAMYCIN PHOSPHATE
>A> @ BOCA PHARMA EQ 1% BASE N62930 001 Jun 28, 1989 Apr CAHN
>D> @ TEVA EQ 1% BASE N62930 001 Jun 28, 1989 Apr CAHN
COLCHICINE; PROBENECID
TABLET; ORAL
COL-PROBENECID
>D> BP + WATSON LABS 0.5MG;500MG N84279 001 Apr CTEC
>A> BP + 0.5MG;500MG N84279 001 Apr CTEC
PROBENECID AND COLCHICINE
>A> AB CONCORD LABS NJ 0.5MG;500MG N40618 001 May 13, 2008 Apr NEWA
CYCLOBENZAPRINE HYDROCHLORIDE
TABLET; ORAL
CYCLOBENZAPRINE HYDROCHLORIDE
>A> AB RANBAXY 5MG N78722 001 May 12, 2008 Apr NEWA
>A> AB 7.5MG N78722 002 May 12, 2008 Apr NEWA
>A> AB 10MG N78722 003 May 12, 2008 Apr NEWA
>D> WATSON LABS 7.5MG N71611 003 Feb 03, 2006 Apr CTEC
>A> AB 7.5MG N71611 003 Feb 03, 2006 Apr CTEC
DEXAMETHASONE
TABLET; ORAL
DEXAMETHASONE
>D> @ LEINER 0.75MG N83420 001 Apr CAHN
>A> @ PVT FORM 0.75MG N83420 001 Apr CAHN
DIGOXIN
INJECTABLE; INJECTION
>D> DIGOXIN PEDIATRIC
>D> AP HOSPIRA 0.1MG/ML N40092 001 Apr 25, 1996 Apr DISC
>A> @ 0.1MG/ML N40092 001 Apr 25, 1996 Apr DISC
LANOXIN PEDIATRIC
>D> AP + GLAXOSMITHKLINE 0.1MG/ML N09330 004 Apr CTEC
>A> + 0.1MG/ML N09330 004 Apr CTEC
DIPHENHYDRAMINE HYDROCHLORIDE
CAPSULE; ORAL
DIPHENHYDRAMINE HYDROCHLORIDE
>D> @ LEINER 25MG N83027 001 Apr CAHN
>D> @ 50MG N83027 002 Apr CAHN
>A> @ PVT FORM 25MG N83027 001 Apr CAHN
>A> @ 50MG N83027 002 Apr CAHN
ELIXIR; ORAL
DIPHENHYDRAMINE HYDROCHLORIDE
>D> @ LEINER 12.5MG/5ML N85287 001 Apr CAHN
>A> @ PVT FORM 12.5MG/5ML N85287 001 Apr CAHN
DIPYRIDAMOLE
TABLET; ORAL
DIPYRIDAMOLE
>A> AB LANNETT 25MG N40898 001 Apr 23, 2008 Apr NEWA
>A> AB 50MG N40898 002 Apr 23, 2008 Apr NEWA
>A> AB 75MG N40898 003 Apr 23, 2008 Apr NEWA
DONEPEZIL HYDROCHLORIDE
TABLET; ORAL
ARICEPT
>D> EISAI MEDCL RES 5MG N20690 002 Nov 25, 1996 Apr CFTG
>A> AB 5MG N20690 002 Nov 25, 1996 Apr CFTG
>D> + 10MG N20690 001 Nov 25, 1996 Apr CFTG
>A> AB + 10MG N20690 001 Nov 25, 1996 Apr CFTG
>A> DONEPEZIL HYDROCHLORIDE
>A> AB TEVA 5MG N77344 001 Apr 28, 2008 Apr NEWA
>A> AB 10MG N77344 002 Apr 28, 2008 Apr NEWA
DOXYCYCLINE
CAPSULE, DELAYED RELEASE; ORAL
ORACEA
>D> + COLLAGENEX 40MG N50805 001 May 26, 2006 Apr CAHN
>A> + GALDERMA LABS LP 40MG N50805 001 May 26, 2006 Apr CAHN
DOXYCYCLINE HYCLATE
CAPSULE; ORAL
DOXYCYCLINE HYCLATE
>D> @ LEINER EQ 100MG BASE N62631 002 Jul 24, 1986 Apr CAHN
>A> @ PVT FORM EQ 100MG BASE N62631 002 Jul 24, 1986 Apr CAHN
TABLET; ORAL
PERIOSTAT
>D> AB + COLLAGENEX EQ 20MG BASE N50783 001 Feb 02, 2001 Apr CAHN
>A> AB + GALDERMA LABS LP EQ 20MG BASE N50783 001 Feb 02, 2001 Apr CAHN
DROSPIRENONE; ETHINYL ESTRADIOL
TABLET; ORAL-28
>A> DROSPIRENONE AND ETHINYL ESTRADIOL
>A> AB BARR 3MG;0.03MG N77527 001 May 09, 2008 Apr NEWA
YASMIN
>D> + BAYER HLTHCARE 3MG;0.03MG N21098 001 May 11, 2001 Apr CFTG
>A> AB + 3MG;0.03MG N21098 001 May 11, 2001 Apr CFTG
EPINEPHRINE; LIDOCAINE HYDROCHLORIDE
INJECTABLE; INJECTION
LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE
>D> AP HOSPIRA 0.005MG/ML;1.5% N89650 001 Jun 21, 1988 Apr DISC
>A> @ 0.005MG/ML;1.5% N89650 001 Jun 21, 1988 Apr DISC
>A> AP 0.01MG/ML;2% N78772 001 May 12, 2008 Apr NEWA
>A> AP 0.02MG/ML;2% N78772 002 May 12, 2008 Apr NEWA
XYLOCAINE W/ EPINEPHRINE
>D> + DENTSPLY PHARM 0.01MG/ML;2% N21381 001 Apr CFTG
>A> AP + 0.01MG/ML;2% N21381 001 Apr CFTG
>D> + 0.02MG/ML;2% N21381 002 Apr CFTG
>A> AP + 0.02MG/ML;2% N21381 002 Apr CFTG
EPOPROSTENOL SODIUM
INJECTABLE; INJECTION
>A> EPOPROSTENOL SODIUM
>A> AP TEVA PARENTERAL EQ 0.5MG BASE/VIAL N78396 001 Apr 23, 2008 Apr NEWA
>A> AP EQ 1.5MG BASE/VIAL N78396 002 Apr 23, 2008 Apr NEWA
FLOLAN
>D> + GLAXOSMITHKLINE EQ 0.5MG BASE/VIAL N20444 001 Sep 20, 1995 Apr CFTG
>A> AP + EQ 0.5MG BASE/VIAL N20444 001 Sep 20, 1995 Apr CFTG
>D> + EQ 1.5MG BASE/VIAL N20444 002 Sep 20, 1995 Apr CFTG
>A> AP + EQ 1.5MG BASE/VIAL N20444 002 Sep 20, 1995 Apr CFTG
ESTROGENS, ESTERIFIED
TABLET; ORAL
ESTERIFIED ESTROGENS
>D> @ LEINER 0.625MG N83414 001 Apr CAHN
>D> @ 1.25MG N83765 001 Apr CAHN
>D> @ 2.5MG N85907 001 Apr CAHN
>A> @ PVT FORM 0.625MG N83414 001 Apr CAHN
>A> @ 1.25MG N83765 001 Apr CAHN
>A> @ 2.5MG N85907 001 Apr CAHN
FEMOGEN
>D> @ LEINER 0.625MG N85076 001 Apr CAHN
>D> @ 1.25MG N85008 001 Apr CAHN
>D> @ 2.5MG N85007 001 Apr CAHN
>A> @ PVT FORM 0.625MG N85076 001 Apr CAHN
>A> @ 1.25MG N85008 001 Apr CAHN
>A> @ 2.5MG N85007 001 Apr CAHN
ETHIONAMIDE
TABLET; ORAL
>A> TRECATOR
>A> + WYETH PHARMS 250MG N13026 002 Apr CTNA
>D> TRECATOR-SC
>D> + WYETH PHARMS 250MG N13026 002 Apr CTNA
FENOFIBRATE
TABLET; ORAL
FENOFIBRATE
>D> LIFECYCLE 40MG N22118 001 Aug 10, 2007 Apr CAHN
>D> + 120MG N22118 002 Aug 10, 2007 Apr CAHN
>A> SCIELE PHARMA 40MG N22118 001 Aug 10, 2007 Apr CAHN
>A> + 120MG N22118 002 Aug 10, 2007 Apr CAHN
FLUMAZENIL
INJECTABLE; INJECTION
>A> AP FLAKORN STRIDES 0.5MG/5ML(0.1MG/ML) N78595 001 May 13, 2008 Apr NEWA
>A> AP 1MG/10ML(0.1MG/ML) N78595 002 May 13, 2008 Apr NEWA
FLUVOXAMINE MALEATE
TABLET; ORAL
LUVOX
>A> AB JAZZ 25MG N21519 001 Dec 20, 2007 Apr CAHN
>A> AB 50MG N21519 002 Dec 20, 2007 Apr CAHN
>A> AB 100MG N21519 003 Dec 20, 2007 Apr CAHN
>D> AB SOLVAY 25MG N21519 001 Dec 20, 2007 Apr CAHN
>D> AB 50MG N21519 002 Dec 20, 2007 Apr CAHN
>D> AB 100MG N21519 003 Dec 20, 2007 Apr CAHN
FUROSEMIDE
INJECTABLE; INJECTION
FUROSEMIDE
>D> AP HOSPIRA 10MG/ML N74337 001 Oct 31, 1994 Apr DISC
>A> @ 10MG/ML N74337 001 Oct 31, 1994 Apr DISC
GRANISETRON HYDROCHLORIDE
INJECTABLE; INJECTION
GRANISETRON HYDROCHLORIDE
>A> AP EBEWE PARENTA EQ 0.1MG BASE/ML (EQ 0.1MG N78808 001 Apr 29, 2008 Apr NEWA
GRISEOFULVIN, MICROCRYSTALLINE
SUSPENSION; ORAL
GRISEOFULVIN
>A> AB PERRIGO CO 125MG/5ML N65200 001 Mar 02, 2005 Apr CAHN
>D> AB STIEFEL 125MG/5ML N65200 001 Mar 02, 2005 Apr CAHN
HYDROCHLOROTHIAZIDE
TABLET; ORAL
HYDROCHLOROTHIAZIDE
>D> @ LEINER 50MG N86597 001 Apr CAHN
>A> @ PVT FORM 50MG N86597 001 Apr CAHN
IBUPROFEN
TABLET; ORAL
IBUPROFEN
>D> AB LEINER 300MG N71266 001 Oct 15, 1986 Apr DISC
>A> @ 300MG N71266 001 Oct 15, 1986 Apr DISC
IRINOTECAN HYDROCHLORIDE
INJECTABLE; INJECTION
IRINOTECAN HYDROCHLORIDE
>A> AP SUN PHARMA 40MG/2ML (20MG/ML) N78805 001 Apr 21, 2008 Apr NEWA
>A> AP 100MG/5ML (20MG/ML) N78805 002 Apr 21, 2008 Apr NEWA
ISOPROTERENOL HYDROCHLORIDE
INJECTABLE; INJECTION
ISOPROTERENOL HYDROCHLORIDE
>D> HOSPIRA 0.02MG/ML N83283 001 Apr DISC
>A> @ 0.02MG/ML N83283 001 Apr DISC
LEUPROLIDE ACETATE
INLUPRON
>A> AP + ABBOTT ENDO 1MG/0.2ML N19010 001 Apr 09, 1985 Apr CAHN
>D> AP + TAP PHARM 1MG/0.2ML N19010 001 Apr 09, 1985 Apr CAHN
LUPRON DEPOT
>A> + ABBOTT ENDO 3.75MG/VIAL N20011 001 Oct 22, 1990 Apr CAHN
>A> + 7.5MG/VIAL N19732 001 Jan 26, 1989 Apr CAHN
>A> + 22.5MG/VIAL N20517 001 Dec 22, 1995 Apr CAHN
>D> + TAP PHARM 3.75MG/VIAL N20011 001 Oct 22, 1990 Apr CAHN
>D> + 7.5MG/VIAL N19732 001 Jan 26, 1989 Apr CAHN
>D> + 22.5MG/VIAL N20517 001 Dec 22, 1995 Apr CAHN
LUPRON DEPOT-3
>A> + ABBOTT ENDO 11.25MG/VIAL N20708 001 Mar 07, 1997 Apr CAHN
>D> + TAP PHARM 11.25MG/VIAL N20708 001 Mar 07, 1997 Apr CAHN
LUPRON DEPOT-4
>A> + ABBOTT ENDO 30MG/VIAL N20517 002 May 30, 1997 Apr CAHN
>D> + TAP PHARM 30MG/VIAL N20517 002 May 30, 1997 Apr CAHN
>A> @ ABBOTT ENDO 3.75MG/VIAL,7.5MG/VIAL N20263 003 Apr 16, 1993 Apr CAHN
>A> + 7.5MG/VIAL N20263 002 Apr 16, 1993 Apr CAHN
>A> @ 3.75MG/VIAL,7.5MG/VIAL N20263 003 Apr 16, 1993 Apr CAHN
>A> @ 7.5MG/VIAL,7.5MG/VIAL N20263 004 Apr 16, 1993 Apr CAHN
>A> + 11.25MG/VIAL N20263 005 Jan 21, 1994 Apr CAHN
>A> + 15MG/VIAL N20263 006 Jan 21, 1994 Apr CAHN
>D> @ TAP PHARM 3.75MG/VIAL,7.5MG/VIAL N20263 003 Apr 16, 1993 Apr CAHN
>D> + 7.5MG/VIAL N20263 002 Apr 16, 1993 Apr CAHN
>D> @ 3.75MG/VIAL,7.5MG/VIAL N20263 003 Apr 16, 1993 Apr CAHN
>D> @ 7.5MG/VIAL,7.5MG/VIAL N20263 004 Apr 16, 1993 Apr CAHN
>D> + 11.25MG/VIAL N20263 005 Jan 21, 1994 Apr CAHN
>D> + 15MG/VIAL N20263 006 Jan 21, 1994 Apr CAHN
LIDOCAINE HYDROCHLORIDE
INJECTABLE; INJECTION
XYLOCAINE PRESERVATIVE FREE
>D> AP ABRAXIS 1% N16801 005 Jan 19, 1988 Apr CAHN
>D> AP + 2% N16801 001 Apr CAHN
>D> AP 4% N16801 002 Apr CAHN
>D> AP + 10% N16801 003 Apr CAHN
>D> AP + 20% N16801 004 Apr CAHN
>A> AP APP PHARMS 1% N16801 005 Jan 19, 1988 Apr CAHN
>A> AP + 2% N16801 001 Apr CAHN
>A> AP 4% N16801 002 Apr CAHN
>A> AP + 10% N16801 003 Apr CAHN
>A> AP + 20% N16801 004 Apr CAHN
LUBIPROSTONE
CAPSULE; ORAL
AMITIZA
>A> SUCAMPO PHARMS 8UGM N21908 002 Apr 29, 2008 Apr NEWA
MEPIVACAINE HYDROCHLORIDE
INJECTABLE; INJECTION
MEPIVACAINE HYDROCHLORIDE
>A> AP HOSPIRA INC 3% N40806 001 Apr 28, 2008 Apr NEWA
MEPROBAMATE
TABLET; ORAL
MEPROBAMATE
>D> @ LEINER 400MG N14601 001 Apr CAHN
>A> @ PVT FORM 400MG N14601 001 Apr CAHN
METHSCOPOLAMINE BROMIDE
TABLET; ORAL
METHSCOPOLAMINE BROMIDE
>D> @ LEINER 2.5MG N80970 001 Apr CAHN
>A> @ PVT FORM 2.5MG N80970 001 Apr CAHN
>A> METHYLNALTREXONE BROMIDE
>A> SOLUTION; SUBCUTANEOUS
>A> RELISTOR
>A> + PROGENICS 12MG/0.6ML (12MG/0.6ML) N21964 001 Apr 24, 2008 Apr NEWA
METHYLPHENIDATE
FILM, EXTENDED RELEASE; TRANSDERMAL
DAYTRANA
>D> + SHIRE 10MG/9HR (1.1MG/HR) N21514 001 Apr 06, 2006 Apr CRLD
>A> 10MG/9HR (1.1MG/HR) N21514 001 Apr 06, 2006 Apr CRLD
>D> + 15MG/9HR (1.6MG/HR) N21514 002 Apr 06, 2006 Apr CRLD
>A> 15MG/9HR (1.6MG/HR) N21514 002 Apr 06, 2006 Apr CRLD
>D> + 20MG/9HR (2.2MG/HR) N21514 003 Apr 06, 2006 Apr CRLD
>A> 20MG/9HR (2.2MG/HR) N21514 003 Apr 06, 2006 Apr CRLD
METHYLTESTOSTERONE
TABLET; BUCCAL/SUBLINGUAL
METHYLTESTOSTERONE
>D> @ LEINER 5MG N83836 001 Apr CAHN
>A> @ PVT FORM 5MG N83836 001 Apr CAHN
TABLET; ORAL
METHYLTESTOSTERONE
>D> @ LEINER 5MG N80214 001 Apr CAHN
>D> @ 10MG N80214 002 Apr CAHN
>D> @ 25MG N80214 003 Apr CAHN
>A> @ PVT FORM 5MG N80214 001 Apr CAHN
>A> @ 10MG N80214 002 Apr CAHN
>A> @ 25MG N80214 003 Apr CAHN
METOPROLOL TARTRATE
INJECTABLE; INJECTION
METOPROLOL TARTRATE
>A> AP HOSPIRA 1MG/ML N78085 001 Apr 29, 2008 Apr NEWA
MINOCYCLINE HYDROCHLORIDE
CAPSULE; ORAL
MINOCYCLINE HYDROCHLORIDE
>D> AB TEVA EQ 100MG BASE N63009 001 Mar 02, 1992 Apr CRLD
>A> AB + EQ 100MG BASE N63009 001 Mar 02, 1992 Apr CRLD
MITOXANTRONE HYDROCHLORIDE
INJECTABLE; INJECTION
MITOXANTRONE HYDROCHLORIDE
>A> AP DABUR ONCOLOGY EQ 20MG BASE/10ML(2MG/ML) N78606 001 May 14, 2008 Apr NEWA
>A> AP EQ 25MG BASE/12.5ML(2MG/ML) N78606 002 May 14, 2008 Apr NEWA
>A> AP EQ 30MG BASE/15ML (2MG/ML) N78606 003 May 14, 2008 Apr NEWA
>A> NAPROXEN SODIUM; SUMATRIPTAN SUCCINATE
>A> TABLET; ORAL
>A> TREXIMET
>A> + POZEN 500MG;EQ 85MG BASE N21926 001 Apr 15, 2008 Apr NEWA
NICARDIPINE HYDROCHLORIDE
CAPSULE, EXTENDED RELEASE; ORAL
CARDENE SR
>A> + EKR THERAP 30MG N20005 001 Feb 21, 1992 Apr CAHN
>A> + 45MG N20005 002 Feb 21, 1992 Apr CAHN
>A> + 60MG N20005 003 Feb 21, 1992 Apr CAHN
>D> + PDL BIOPHARMA 30MG N20005 001 Feb 21, 1992 Apr CAHN
>D> + 45MG N20005 002 Feb 21, 1992 Apr CAHN
>D> + 60MG N20005 003 Feb 21, 1992 Apr CAHN
CAPSULE; ORAL
CARDENE
>A> AB EKR THERAP 20MG N19488 001 Dec 21, 1988 Apr CAHN
>A> AB + 30MG N19488 002 Dec 21, 1988 Apr CAHN
>D> AB PDL BIOPHARMA 20MG N19488 001 Dec 21, 1988 Apr CAHN
>D> AB + 30MG N19488 002 Dec 21, 1988 Apr CAHN
INJECTABLE; INJECTION
CARDENE
>A> + EKR THERAP 2.5MG/ML N19734 001 Jan 30, 1992 Apr CAHN
>D> + PDL BIOPHARMA 2.5MG/ML N19734 001 Jan 30, 1992 Apr CAHN
NYSTATIN
SUSPENSION; ORAL
NILSTAT
>A> AA + GLENMARK 100,000 UNITS/ML N50299 001 Apr CAHN
>D> AA + GLENMARK 100,000 UNITS/ML N50299 001 Apr CAHN
OFLOXACIN
>D> INJECTABLE; INJECTION
>D> OFLOXACIN
>D> + BEDFORD 40MG/ML N75762 001 Jan 16, 2002 Apr DISC
>A> @ 40MG/ML N75762 001 Jan 16, 2002 Apr DISC
OLOPATADINE HYDROCHLORIDE
SOLUTION/DROPS; OPHTHALMIC
PATADAY
>D> + ALCON 0.2% N21545 001 Dec 22, 2004 Apr CPOT
>A> + EQ 0.2% BASE N21545 001 Dec 22, 2004 Apr CPOT
>A> SPRAY, METERED; NASAL
>A> + PAALCON 0.665MG/SPRAY N21861 001 Apr 15, 2008 Apr NEWA
ONDANSETRON HYDROCHLORIDE
INJECTABLE; INJECTION
ONDANSETRON HYDROCHLORIDE
>A> AP AKORN STRIDES EQ 2MG BASE/ML N78257 001 Apr 23, 2008 Apr NEWA
ONDANSETRON HYDROCHLORIDE PRESERVATIVE FREE
>A> AP AKORN STRIDES EQ 2MG BASE/ML N78244 001 Apr 23, 2008 Apr NEWA
PENICILLIN V POTASSIUM
TABLET; ORAL
PENICILLIN V POTASSIUM
>A> AB AUROBINDO EQ 250MG BASE N65435 001 Apr 29, 2008 Apr NEWA
>A> AB EQ 500MG BASE N65435 002 Apr 29, 2008 Apr NEWA
PHENDIMETRAZINE TARTRATE
TABLET; ORAL
DI-METREX
>D> @ LEINER 35MG N85698 001 Apr CAHN
>A> @ PVT FORM 35MG N85698 001 Apr CAHN
PHENDIMETRAZINE TARTRATE
>D> @ LEINER 35MG N85697 001 Apr CAHN
>D> @ 35MG N85199 001 Apr CAHN
>A> @ PVT FORM 35MG N85697 001 Apr CAHN
>A> @ 35MG N85199 001 Apr CAHN
PHENTERMINE HYDROCHLORIDE
CAPSULE; ORAL
PHENTERMINE HYDROCHLORIDE
>A> AA KVK TECH 37.5MG N40887 001 Apr 24, 2008 Apr NEWA
PRAVASTATIN SODIUM
TABLET; ORAL
PRAVASTATIN SODIUM
>A> AB ZYDUS PHARMS USA 10MG N77751 001 Apr 30, 2008 Apr NEWA
>A> AB 20MG N77751 002 Apr 30, 2008 Apr NEWA
>A> AB 40MG N77751 003 Apr 30, 2008 Apr NEWA
>A> AB 80MG N77751 004 Apr 30, 2008 Apr NEWA
PREDNISOLONE
TABLET; ORAL
PREDNISOLONE
>D> @ LEINER 5MG N80211 001 Apr CAHN
>A> @ PVT FORM 5MG N80211 001 Apr CAHN
PREDNISOLONE SODIUM PHOSPHATE
SOLUTION; ORAL
PREDNISOLONE SODIUM PHOSPHATE
>D> AA PHARM ASSOC EQ 10MG BASE/5ML N78465 001 Mar 07, 2008 Apr CRLD
>A> + EQ 10MG BASE/5ML N78465 001 Mar 07, 2008 Apr CRLD
PREDNISONE
TABLET; ORAL
PREDNISONE
>D> @ LEINER 20MG N85151 001 Apr CAHN
>A> @ PVT FORM 20MG N85151 001 Apr CAHN
PRIMIDONE
TABLET; ORAL
PRIMIDONE
>A> AB AMNEAL PHARM 50MG N40866 001 Apr 23, 2008 Apr NEWA
>A> AB 250MG N40866 002 Apr 23, 2008 Apr NEWA
PROCAINAMIDE HYDROCHLORIDE
INJECTABLE; INJECTION
>D> PRONESTYL
>D> AP + APOTHECON 100MG/ML N07335 002 Apr DISC
>A> @ 100MG/ML N07335 002 Apr DISC
>D> AP + 500MG/ML N07335 005 Apr DISC
>A> @ 500MG/ML N07335 005 Apr DISC
>D> TABLET; ORAL
>D> PRONESTYL
>D> APOTHECON 250MG N17371 001 Apr DISC
>A> @ 250MG N17371 001 Apr DISC
>D> 375MG N17371 002 Apr DISC
>A> @ 375MG N17371 002 Apr DISC
>D> + 500MG N17371 003 Apr DISC
>A> @ 500MG N17371 003 Apr DISC
PROMETHAZINE HYDROCHLORIDE
INJECTABLE; INJECTION
PROMETHAZINE HYDROCHLORIDE
>A> AP HIKMA 25MG/ML N40737 001 Apr 24, 2008 Apr NEWA
>A> AP 50MG/ML N40737 002 Apr 24, 2008 Apr NEWA
>D> AP HOSPIRA 50MG/ML N83838 002 Apr DISC
>A> @ 50MG/ML N83838 002 Apr DISC
TABLET; ORAL
PROMETHAZINE HYDROCHLORIDE
>D> @ LEINER 12.5MG N83214 001 Apr CAHN
>D> @ 25MG N83658 001 Apr CAHN
>A> @ PVT FORM 12.5MG N83214 001 Apr CAHN
>A> @ 25MG N83658 001 Apr CAHN
>D> BP WATSON LABS 25MG N83426 001 Apr CTEC
>A> AB 25MG N83426 001 Apr CTEC
>D> BP 50MG N83711 001 Apr CTEC
>A> AB 50MG N83711 001 Apr CTEC
PROPANTHELINE BROMIDE
TABLET; ORAL
PROPANTHELINE BROMIDE
>D> @ LEINER 15MG N80977 001 Apr CAHN
>A> @ PVT FORM 15MG N80977 001 Apr CAHN
PROPOXYPHENE HYDROCHLORIDE
CAPSULE; ORAL
PROPOXYPHENE HYDROCHLORIDE
>D> @ LEINER 32MG N83464 001 Apr CAHN
>D> @ 65MG N83113 001 Apr CAHN
>A> @ PVT FORM 32MG N83464 001 Apr CAHN
>A> @ 65MG N83113 001 Apr CAHN
PSEUDOEPHEDRINE HYDROCHLORIDE; TRIPROLIDINE HYDROCHLORIDE
TABLET; ORAL
ALLERFED
>D> @ LEINER 60MG;2.5MG N88860 001 Jan 31, 1985 Apr CAHN
>A> @ PVT FORM 60MG;2.5MG N88860 001 Jan 31, 1985 Apr CAHN
QUETIAPINE FUMARATE
TABLET, EXTENDED RELEASE; ORAL
SEROQUEL XR
>D> ASTRAZENECA EQ 50MG BASE N22047 001 May 17, 2007 Apr DISC
>A> @ EQ 50MG BASE N22047 001 May 17, 2007 Apr DISC
RAMIPRIL
CAPSULE; ORAL
RAMIPRIL
>D> AB COBALT 1.25MG N76549 001 Oct 24, 2005 Apr CAHN
>D> AB 2.5MG N76549 002 Oct 24, 2005 Apr CAHN
>D> AB 5MG N76549 003 Oct 24, 2005 Apr CAHN
>D> AB 10MG N76549 004 Oct 24, 2005 Apr CAHN
>A> AB COBALT LABS INC 1.25MG N76549 001 Oct 24, 2005 Apr CAHN
>A> AB 2.5MG N76549 002 Oct 24, 2005 Apr CAHN
>A> AB 5MG N76549 003 Oct 24, 2005 Apr CAHN
>A> AB 10MG N76549 004 Oct 24, 2005 Apr CAHN
RAUWOLFIA SERPENTINA
TABLET; ORAL
RAUWOLFIA SERPENTINA
>D> @ LEINER 50MG N80583 001 Apr CAHN
>D> @ 100MG N80583 002 Apr CAHN
>A> @ PVT FORM 50MG N80583 001 Apr CAHN
>A> @ 100MG N80583 002 Apr CAHN
>A> REGADENOSON
>A> INJECTABLE; INJECTION
>A> LEXISCAN
>A> + CV THERAP 0.4MG/5ML (0.08MG/ML) N22161 001 Apr 10, 2008 Apr NEWA
RESERPINE
TABLET; ORAL
RESERPINE
>D> @ LEINER 0.1MG N86117 001 Apr CAHN
>D> @ 0.25MG N85775 001 Apr CAHN
>D> @ 0.25MG N80582 001 Apr CAHN
>D> @ 1MG N80582 002 Apr CAHN
>A> @ PVT FORM 0.1MG N86117 001 Apr CAHN
>A> @ 0.25MG N85775 001 Apr CAHN
>A> @ 0.25MG N80582 001 Apr CAHN
>A> @ 1MG N80582 002 Apr CAHN
RIBAVIRIN
TABLET; ORAL
RIBAVIRIN
>A> ZYDUS PHARMS USA 500MG N77094 004 Apr 18, 2008 Apr NEWA
RISEDRONATE SODIUM
TABLET; ORAL
ACTONEL
>A> PROCTER AND 150MG N20835 005 Apr 22, 2008 Apr NEWA
ROPINIROLE HYDROCHLORIDE
TABLET; ORAL
REQUIP
>D> + GLAXOSMITHKLINE EQ 0.25MG BASE N20658 001 Sep 19, 1997 Apr CFTG
>A> AB + EQ 0.25MG BASE N20658 001 Sep 19, 1997 Apr CFTG
>D> EQ 0.5MG BASE N20658 002 Sep 19, 1997 Apr CFTG
>A> AB EQ 0.5MG BASE N20658 002 Sep 19, 1997 Apr CFTG
>D> EQ 1MG BASE N20658 003 Sep 19, 1997 Apr CFTG
>A> AB EQ 1MG BASE N20658 003 Sep 19, 1997 Apr CFTG
>D> EQ 2MG BASE N20658 004 Sep 19, 1997 Apr CFTG
>A> AB EQ 2MG BASE N20658 004 Sep 19, 1997 Apr CFTG
>D> EQ 3MG BASE N20658 006 Jan 27, 1999 Apr CFTG
>A> AB EQ 3MG BASE N20658 006 Jan 27, 1999 Apr CFTG
>D> EQ 4MG BASE N20658 007 Jan 27, 1999 Apr CFTG
>A> AB EQ 4MG BASE N20658 007 Jan 27, 1999 Apr CFTG
>A> ROPINIROLE HYDROCHLORIDE
>A> AB MYLAN EQ 0.25MG BASE N78881 001 May 05, 2008 Apr NEWA
>A> AB EQ 0.5MG BASE N78881 002 May 05, 2008 Apr NEWA
>A> AB EQ 1MG BASE N78881 003 May 05, 2008 Apr NEWA
>A> AB EQ 2MG BASE N78881 004 May 05, 2008 Apr NEWA
>A> AB EQ 3MG BASE N78881 005 May 05, 2008 Apr NEWA
>A> AB EQ 4MG BASE N78881 006 May 05, 2008 Apr NEWA
>A> AB PAR PHARM EQ 0.25MG BASE N78110 001 May 05, 2008 Apr NEWA
>A> AB EQ 0.5MG BASE N78110 002 May 05, 2008 Apr NEWA
>A> AB EQ 1MG BASE N78110 003 May 05, 2008 Apr NEWA
>A> AB EQ 2MG BASE N78110 004 May 05, 2008 Apr NEWA
>A> AB EQ 3MG BASE N78110 005 May 05, 2008 Apr NEWA
>A> AB EQ 4MG BASE N78110 006 May 05, 2008 Apr NEWA
>A> AB ROXANE EQ 0.25MG BASE N77852 001 May 05, 2008 Apr NEWA
>A> AB EQ 0.5MG BASE N77852 002 May 05, 2008 Apr NEWA
>A> AB EQ 1MG BASE N77852 003 May 05, 2008 Apr NEWA
>A> AB EQ 2MG BASE N77852 004 May 05, 2008 Apr NEWA
>A> AB EQ 3MG BASE N77852 005 May 05, 2008 Apr NEWA
>A> AB EQ 4MG BASE N77852 006 May 05, 2008 Apr NEWA
>A> AB TEVA EQ 0.25MG BASE N77460 001 May 05, 2008 Apr NEWA
>A> AB EQ 0.5MG BASE N77460 002 May 05, 2008 Apr NEWA
>A> AB EQ 1MG BASE N77460 003 May 05, 2008 Apr NEWA
>A> AB EQ 2MG BASE N77460 004 May 05, 2008 Apr NEWA
>A> AB EQ 3MG BASE N77460 005 May 05, 2008 Apr NEWA
>A> AB EQ 4MG BASE N77460 006 May 05, 2008 Apr NEWA
>D> ROTIGOTINE
>D> FILM, EXTENDED RELEASE; TRANSDERMAL
>D> NEUPRO
>D> SCHWARZ 2MG/24HR N21829 001 May 09, 2007 Apr DISC
>A> @ 2MG/24HR N21829 001 May 09, 2007 Apr DISC
>D> 4MG/24HR N21829 002 May 09, 2007 Apr DISC
>A> @ 4MG/24HR N21829 002 May 09, 2007 Apr DISC
>D> + 6MG/24HR N21829 003 May 09, 2007 Apr DISC
>A> @ 6MG/24HR N21829 003 May 09, 2007 Apr DISC
SODIUM LACTATE
INJECTABLE; INJECTION
SODIUM LACTATE 0.167 MOLAR IN PLASTIC CONTAINER
>D> AP HOSPIRA 1.87GM/100ML N18249 001 Apr DISC
>A> @ 1.87GM/100ML N18249 001 Apr DISC
TETRACYCLINE HYDROCHLORIDE
CAPSULE; ORAL
TETRACYCLINE HYDROCHLORIDE
>D> @ LEINER 250MG N62686 001 Jul 24, 1986 Apr CAHN
>D> @ 500MG N62686 002 Jul 24, 1986 Apr CAHN
>A> @ PVT FORM 250MG N62686 001 Jul 24, 1986 Apr CAHN
>A> @ 500MG N62686 002 Jul 24, 1986 Apr CAHN
THALLOUS CHLORIDE, TL-201
INJECTABLE; INTRAVENOUS
THALLOUS CHLORIDE TL 201
>A> AP MALLINCKRODT 2mCi/ML N77698 001 Nov 09, 2006 Apr CAHN
>D> AP TCI MEDCL 2mCi/ML N77698 001 Nov 09, 2006 Apr CAHN
TIMOLOL MALEATE
SOLUTION/DROPS; OPHTHALMIC
TIMOLOL MALEATE
>A> AT FDC LTD EQ 0.25% BASE N77259 001 Apr 30, 2008 Apr NEWA
>A> AT EQ 0.5% BASE N77259 002 Apr 30, 2008 Apr NEWA
TRANDOLAPRIL
TABLET; ORAL
TRANDOLAPRIL
>A> AB MYLAN 1MG N78346 001 Apr 28, 2008 Apr NEWA
>A> AB 2MG N78346 002 Apr 28, 2008 Apr NEWA
>A> AB 4MG N78346 003 Apr 28, 2008 Apr NEWA
VECURONIUM BROMIDE
INJECTABLE; INJECTION
VECURONIUM BROMIDE
>D> + HOSPIRA 4MG/VIAL N75558 001 Sep 11, 2001 Apr DISC
>A> @ 4MG/VIAL N75558 001 Sep 11, 2001 Apr DISC
ZIDOVUDINE
TABLET; ORAL
ZIDOVUDINE
>A> AB HETERO DRUGS LTD 300MG N90092 001 Apr 25, 2008 Apr NEWA
ZOLPIDEM TARTRATE
TABLET; ORAL
ZOLPIDEM TARTRATE
>A> AB HIKMA 5MG N78129 001 Apr 30, 2008 Apr NEWA
>A> AB 10MG N78129 002 Apr 30, 2008 Apr NEWA
CETIRIZINE HYDROCHLORIDE
SYRUP; ORAL
CHILDREN'S CETIRIZINE HYDROCHLORIDE ALLERGY
>A> ACTAVIS MID 5MG/5ML N90378 002 May 09, 2008 Apr NEWA
>A> APOTEX 5MG/5ML N90188 002 Apr 22, 2008 Apr NEWA
>A> RANBAXY 5MG/5ML N90183 002 Apr 24, 2008 Apr NEWA
>A> TARO 5MG/5ML N90182 002 Apr 22, 2008 Apr NEWA
CHILDREN'S CETIRIZINE HYDROCHLORIDE HIVES RELIEF
>A> ACTAVIS MID 5MG/5ML N90378 001 May 09, 2008 Apr NEWA
>A> APOTEX 5MG/5ML N90188 001 Apr 22, 2008 Apr NEWA
>A> RANBAXY 5MG/5ML N90183 001 Apr 24, 2008 Apr NEWA
>A> TARO 5MG/5ML N90182 001 Apr 22, 2008 Apr NEWA
TABLET; ORAL
CETIRIZINE HYDROCHLORIDE ALLERGY
>A> CONTRACT 5MG N76047 001 Dec 27, 2007 Apr CAHN
>A> 10MG N76047 002 Dec 27, 2007 Apr CAHN
>D> PAR PHARM 5MG N76047 001 Dec 27, 2007 Apr CAHN
>D> 10MG N76047 002 Dec 27, 2007 Apr CAHN
CETIRIZINE HYDROCHLORIDE HIVES
>A> CONTRACT 5MG N76047 003 Dec 27, 2007 Apr CAHN
>A> 10MG N76047 004 Dec 27, 2007 Apr CAHN
>D> PAR PHARM 5MG N76047 003 Dec 27, 2007 Apr CAHN
>D> 10MG N76047 004 Dec 27, 2007 Apr CAHN
LOPERAMIDE HYDROCHLORIDE; SIMETHICONE
TABLET, CHEWABLE; ORAL
>D> IMODIUM ADVANCED
>D> + MCNEIL 2MG;125MG N20606 001 Jun 26, 1996 Apr CTNA
>A> IMODIUM MULTI-SYMPTOM RELIEF
>A> + MCNEIL 2MG;125MG N20606 001 Jun 26, 1996 Apr CTNA
TABLET; ORAL
>D> IMODIUM ADVANCED
>D> + MCNEIL CONS 2MG;125MG N21140 001 Nov 30, 2000 Apr CTNA
>A> IMODIUM MULTI-SYMPTOM RELIEF
>A> + MCNEIL CONS 2MG;125MG N21140 001 Nov 30, 2000 Apr CTNA
NICOTINE POLACRILEX
GUM, CHEWING; BUCCAL
NICOTINE POLACRILEX
>A> PERRIGO R AND D EQ 2MG BASE N78967 001 Apr 23, 2008 Apr NEWA
>A> EQ 4MG BASE N78968 001 Apr 23, 2008 Apr NEWA
 Back
to Top 
Back to Additions/Deletions Index
Date created: May 14, 2008 |
|
